INVO Fertility stock gains 2.05 percent as Q2 profit returns

INVO Fertility stock gained 2.05 percent to USD 1.02 on Nasdaq on September 23, 2026, giving the fertility-services company a market capitalization of USD 1,821,756. The move followed second-quarter results that combined higher revenue with a return to reported net income.

Revenue rises 17 percent

For the quarter ended June 30, 2026, revenue reached USD 2,175,485, up 17 percent from USD 1,863,654 a year earlier, according to StockTitan. Clinic revenue accounted for USD 2,167,785, an 18 percent year-over-year increase.

The operating result remained negative at USD 1,289,650, but the deficit narrowed from USD 2,990,088 in Q2 2025. That comparison matters because the revenue gain was accompanied by lower selling, general and administrative expenses of USD 1,906,750.

Profit returns through special gain

INVO Fertility reported net income of USD 888,740 in Q2 2026, compared with a net loss of USD 3,618,969 in the year-earlier quarter, the same StockTitan filing summary shows. The result included a USD 2,452,032 gain from remeasurement related to the Birmingham clinic acquisition.

Underlying operating performance was more restrained. Company-wide adjusted EBITDA was negative USD 1,032,660, compared with negative USD 587,229 a year earlier, while clinic-level adjusted EBITDA improved to USD 333,026 from USD 163,945 in Q1 2026.

Cash burn remains a key metric

Cash and cash equivalents stood at USD 3,732,945 on June 30, 2026, down from USD 4,904,455 on March 31, 2026. Operating cash flow was negative USD 1,101,447 in Q2, following negative USD 1,916,575 in Q1.

For investors, the quarterly picture is therefore two-sided: revenue and clinic profitability improved, while consolidated adjusted EBITDA and operating cash flow remained negative. The USD 1.02 Nasdaq price on September 23, 2026, sat within a 52-week range of USD 0.90 to USD 84.40, highlighting the stock's unusually wide trading history.

Stock trades at USD 1.02

INVO Fertility stock stood at USD 1.02 on Nasdaq on September 23, 2026, up 2.05 percent from the previous close of USD 1.00. The company is listed as NASDAQ:IVF, replacing the former NASDAQ:INVO symbol, according to MarketBeat.